A comprehensive view of Rx-to-OTC Switch. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

FDA advisory committee votes unanimously in favor of approving 4 mg Narcan naloxone HCl nasal spray for over-the counter use as opioid reversal agent; CDC reports over 107,000 people in US died from drug overdoses in 2021
Published: February 17, 2023 by GlobeNewswire
FDA states 4 mg naloxone nasal spray and 2 mg intramuscular autoinjector delivery overdose reversal med formats may be approvable for OTC use; FDA singled out Kaleo’s Evzio prefilled autoinjector, Emergent BioSolutions' Narca nasal spray as candidates
Published: November 18, 2022 by FiercePharma
Over 77% of reproductive-aged women support prescription-free OTC birth control pills because of convenience; studies suggest OTC birth control would increase use of contraception, facilitate continuity of use: Kaiser Family Foundation
Published: November 15, 2022 by MedCityNews.com
FDA postpones decision date regarding whether to allow OTC sales of Perrigo’s prescription Opill birth control drug by 90 days; decision was originally scheduled for first half of 2023
Published: October 27, 2022 by FiercePharma
Fitch: New FDA ruling that creates new category of OTC hearing aids in US will significantly expand access; total hearing aids market expected to expand at 2021-2026 CAGR of 4.2%, making it among fastest growing sub-categories in wider patient aids market
Published: August 18, 2022 by Fitch Solutions Sector Intelligence

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count